SOLZY
Live / Allowed — Notice of allowance issued (as of 31 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 19 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99345441
- Mark type
- Stylized text
- Filed
- 19 Aug 2025
- Published for opposition
- 03 Feb 2026
- Attorney of record
- Anna Kurian Shaw
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and therapeutic agents for treating genetic, neurological, neurodevelopmental, developmental, and central nervous system disorders and diseases having neurological and neurobehavioral symptoms or manifestations; medicated skin care preparations, namely, creams and lotions; medicated skin care preparations, namely, creams and lotions for treating genetic, neurological, neurodevelopmental, developmental, and central nervous system disorders and diseases having neurological and neurobehavioral symptoms or manifestations; transdermal patches featuring pharmaceutical preparations and therapeutic agents for treating genetic, neurological, neurodevelopmental, developmental, and central nervous system disorders and diseases having neurological and neurobehavioral symptoms or manifestations; pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurodevelopmental diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech disorders and diseases, traumatic brain injury, and viral diseases and disorders; Pharmaceutical preparations for the treatment of fragile x syndrome, substance related addiction, autism and autism spectrum disorders, epilepsy, seizure diseases and disorders, anxiety, aphasias, stuttering, post-traumatic stress disorder
Owner
- Harmony Biosciences Management, Inc., Plymouth Meeting, PA, US
- Harmony Biosciences Management, Inc., Plymouth Meeting, PA, US
Prosecution history
- 31 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Feb 2026 — PUBLISHED FOR OPPOSITION
- 28 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Jan 2026 — ASSIGNED TO EXAMINER
- 19 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 19 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 19 Aug 2025 — NEW APPLICATION ENTERED